BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 33916250)

  • 1. Glycomic-Based Biomarkers for Ovarian Cancer: Advances and Challenges.
    Wanyama FM; Blanchard V
    Diagnostics (Basel); 2021 Apr; 11(4):. PubMed ID: 33916250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and emerging biomarkers in ovarian cancer diagnosis; CA125 and beyond.
    Sharma T; Nisar S; Masoodi T; Macha MA; Uddin S; Akil AA; Pandita TK; Singh M; Bhat AA
    Adv Protein Chem Struct Biol; 2023; 133():85-114. PubMed ID: 36707207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancements in protein glycosylation biomarkers for ovarian cancer through mass spectrometry-based approaches.
    Lee J; Park JE; Lee D; Seo N; An HJ
    Expert Rev Mol Diagn; 2024 Apr; 24(4):249-258. PubMed ID: 38112537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of microRNAs in gynecological pathology.
    Gilabert-Estelles J; Braza-Boils A; Ramon LA; Zorio E; Medina P; Espana F; Estelles A
    Curr Med Chem; 2012; 19(15):2406-13. PubMed ID: 22455593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective on ovarian cancer: why prevent?
    Hoskins WJ
    J Cell Biochem Suppl; 1995; 23():189-99. PubMed ID: 8747396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Predictive Biomarkers for Ovarian Cancer.
    Atallah GA; Abd Aziz NH; Teik CK; Shafiee MN; Kampan NC
    Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33800113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein Glycosylation as Biomarkers in Gynecologic Cancers.
    Shen H; Lee CY; Chen CH
    Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review.
    Liberto JM; Chen SY; Shih IM; Wang TH; Wang TL; Pisanic TR
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated glycomic analysis of ovarian cancer side population cells.
    Zhao R; Liu X; Wang Y; Jie X; Qin R; Qin W; Zhang M; Tai H; Yang C; Li L; Peng P; Shao M; Zhang X; Wu H; Ruan Y; Xu C; Ren S; Gu J
    Clin Proteomics; 2016; 13():32. PubMed ID: 27833472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and histopathologic analysis of gynecological cancer: a single institute experience over 7 years.
    Lee SY; Kim E; Kim HS; Koo YJ; Lee DH
    Yeungnam Univ J Med; 2020 Jul; 37(3):179-185. PubMed ID: 32131080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ascites May Provide Useful Information for Diagnosis of Ovarian Cancer].
    Stuchlíková E; Zahradníková M; Nenutil R; Valík D; Vojtěšek B; Novotný M; Hernychova L
    Klin Onkol; 2017; 30(Supplementum1):187-190. PubMed ID: 28471203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of biomarkers for the ovarian cancer diagnosis.
    Zhang B; Cai FF; Zhong XY
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):119-23. PubMed ID: 21632171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycomic Approaches for the Discovery of Targets in Gastrointestinal Cancer.
    Mereiter S; Balmaña M; Gomes J; Magalhães A; Reis CA
    Front Oncol; 2016; 6():55. PubMed ID: 27014630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Biomarkers in the Management of Ovarian Cancer: Current Prospectives.
    Singh A; Gupta S; Sachan M
    Front Cell Dev Biol; 2019; 7():182. PubMed ID: 31608277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 17. Ovarian Cancer Targeted Theranostics.
    Nimmagadda S; Penet MF
    Front Oncol; 2019; 9():1537. PubMed ID: 32039018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and application of protein biomarkers for ovarian cancer.
    Gagnon A; Ye B
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):9-13. PubMed ID: 18196999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian cancer biomarkers: current state and future implications from high-throughput technologies.
    Leung F; Diamandis EP; Kulasingam V
    Adv Clin Chem; 2014; 66():25-77. PubMed ID: 25344985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-associated glycans and their role in gynecological cancers: accelerating translational research by novel high-throughput approaches.
    Pochechueva T; Jacob F; Fedier A; Heinzelmann-Schwarz V
    Metabolites; 2012 Nov; 2(4):913-39. PubMed ID: 24957768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.